Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery

• Status: Not yet recruiting
• Trial end date: 2023-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to compare intranasal dexmedetomidine versus intravenous dexmedetomidine for improving the quality of the operative field in Functional endoscopic sinus surgery (FESS).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kafrelsheikh University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Patients older than 18 years of age

• Both genders

• American Society of Anesthesiologists (ASA) physical status classification I or II

• Undergoing Functional Endoscopic Sinus Surgery.

Exclusion Criteria:

• Patients with a body mass index > 30 kg/m^2

• contraindications to the use of dexmedetomidine

• history or presence of a significant disease

• significant cardiovascular disease risk factors

• significant coronary artery disease or any known genetic predisposition

• history of any kind of drug allergy

• drug abuse

• psychological or other emotional problems

• special diet or lifestyle

• clinically significant abnormal findings in physical examination

• electrocardiographic (ECG) or laboratory screening

• known systemic disease requiring the use of anticoagulants

• patients with a history of previous Functional Endoscopic Sinus Surgery.